Abstract
T cells play a central role in the elimination of both intracellular and extracellular pathogens. Expression of the αβ T cell receptor (TCR) heterodimer enables T cells to specifically recognize peptides presented by major histocompatibility complex (MHC) molecules and generate an immune response to those peptides. CD4+ helper T cells are restricted to MHC class II molecules, and produce cytokines to augment T and B cell responses. CD8+ T cells are restricted to MHC class I molecules, and are generally cytotoxic T lymphocytes (CTLs) whose effector function involves the lysis of infected cells. Broad issues in T cell biology include how mature T cells develop from bone marrow-derived precursors and how T cell activation is regulated. These questions and others have been addressed in many models, including murine TCR transgenic systems, in which the transgenic expression of TCR chains provides a clonal population of antigen-specific T cells that can be readily monitored.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Abastado J-P, Lone Y-C, Casrouge A, Boulot G, Kourilsky P (1995) Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness. J Exp Med 182:439–447
Adler AA, Marsh DW, Yochum GS, Guzzo JL, Nigam A, Nelson WG, Pardoll DM (1998) CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med 187:1555–1564
Aichele P, Kyburz D, Ohashi PS, Odermatt B, Zinkernagel RM, Hengartner H, Pircher H (1994) Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc Natl Acad Sci USA 91:444–448
Alam SM, Davies GM, Lin CM, Zal T, Nasholds W, Jameson SC, Hogquist KA, Gascoigne NR, Travers PJ (1999) Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands. Immunity 10:227–237
Alam SM, Travers PJ, Wung JL, Nasholds W, Redpath S, Jameson SC, Gasciogne NRJ (1996) T-cell-receptor affinity and thymocyte positive selection. Nature 381:616–620
Aldrich CJ, Hammer RE, Jones-Youngblood S, Koszinowski U, Hood L, Stroynowski I, Forman J (1991) Negative and positive selection of antigen-specific cytotoxic T lymphocytes affected by the α3 domain of MHC I molecules. Nature 352:718–721
Ally BA, Hawley TS, MacKall-Faienza K, Kündig TM, Oehen SU, Pircher H, Hawley RG, Ohashi PS (1995) Prevention of autoimmune disease by retroviral-mediated gene therapy. J Immunol 155:5404–5408
Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175–179
Ashton-Rickardt PG, Bandeira A, Delaney JR, Van Kaer L, Pircher HP, Zinkernagel RM, Tonegawa S (1994) Evidence for a differential avidity model of T cell selection in the thymus. Cell 76:651–663
Bachmann MF, Barner M, Kopf M (1999a) CD2 sets quantitative thresholds in T cell activation. J Exp Med 190: 1383–1392
Bachmann MF, Barner M, Viola A, Kopf MF (1999b) Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur J Immunol 29:291–299
Bachmann MF, Gallimore A, Linkert S, Cerundolo V, Lanzavecchia A, Kopf M, Viola A (1999c) Developmental regulation of Lck targeting to the CD8 coreceptor controls signaling in naive and memory T cells. J Exp Med 189:1521–1530
Bachmann MF, Mariathasan S, Bouchard D, Speiser DE, Ohashi PS (1997a) Four types of Ca2+ signals in naive CD8+ cytotoxic T cells after stimulation with T cell agonists, partial agonists and antagonists. Eur J Immunol 27:3414–3419
Bachmann MF, McKall-Faienza K, Schmits R, Bouchard D, Beach J, Speiser DE, Mak TW, Ohashi PS (1997b) Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity 7:1–20
Bachmann MF, Ohashi PS (1999) The role of T cell receptor dimerization in T cell activation. Immunol Today 20:568–576
Bachmann MF, Oxenius A, Speiser DE, Mariathasan S, Hengartner H, Zinkernagel RM, Ohashi PS (1997c) Peptide-induced T cell receptor down-regulation on naive T cells predicts agonist/partial agonist properties and strictly correlates with T cell activation. Eur J Immunol 27:2195–2203
Bachmann MF, Salzmann M, Oxenius A, Ohashi PS (1998a) Formation of TCR dimers/trimers as a crucial step for T cell activation. Eur J Immunol 28:2571–2579
Bachmann MF, Sebzda E, Kündig TM, Shahinian A, Speiser DE, Mak TW, Ohashi PS (1996) T cell responses are governed by avidity and costimulatory thresholds. Eur J Immunol 26:2017–2022
Bachmann MF, Speiser DE, Zakarian A, Ohashi PS (1998b) Inhibition of TCR-triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR-antagonism. Eur J Immunol 28:3110–3119
Bachmann MF, Wong BR, Josien R, Steinman RM, Oxenius A, Choi Y (1999d) TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J Exp Med 189:1025–1031
Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252
Basson MA, Bommhardt U, Cole MS, Tso JY, Zamoyska R (1998) CD3 ligation on immature thymocytes generates antagonist-like signals appropriate for CD8 lineage commitment, independently of T cell receptor specificity. J Exp Med 187:1249–1260
Bevan MJ (1977) In a radiation chimera, host H-2 antigens determine immune responsiveness of donor cytotoxic cells. Nature 269:417–418
Blackman MA, Gerhard-Burgert H, Woodland DL, Palmer E, Kappler JW, Marrack P (1990) A role for elonal inactivation in T cell tolerance to M1s-1a. Nature 345:540–542
Boehme J, Haskins K, Stecha P, van Ewijk W, LeMeur M, Gerlinger P, Benoist C, Mathis D (1989) Transgenic mice with I-A on islet cells are normoglycemic but immunologically intolerant. Science 244:1179–1183
Boniface JJ, Rabinowitz JD, Wulfing C, Hampl J, Reich Z, Altman JD, Kantor RM, Beeson C, McConnell HM, Davis MM (1998) Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected] [published erratum appears in Immunity 1998 Dec;9(6):891]. Immunity 9:459–466
Bretscher P, Cohn M (1970) A theory of self-nonself discrimination. Science 169: 1042–1049
Cai Z, Kishimoto H, Brunmark A, Jackson MR, Peterson PA, Sprent J (1997) Requirements for peptide-induced T cell receptor down regulation on naive CD8+ T cells. J Exp Med 185:641–651
Cantrell D (1996) T cell antigen receptor signal transduction pathways. Annu Rev Immunol 14:259–274
Carbone FR, Kurts C, Bennet SRM, Miller JFAP (1998) Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today 19:368
Cella M, Sallusto F, Lanzavecchia A (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10–16
Chan IT, Limmer A, Louie MC, Bullock ED, Fung-Leung WP, Mak TW, Loh DY (1993) Thymic selection of cytotoxic T cells independent of CD8α-lck association. Science 261: 1581–1584
Chidgey A, Boyd R (1997) Agonist peptide modulates T cell selection thresholds through qualitative and quantitative shifts in CD8 co-receptor expression. Int Immunol 9:1527–1536
Chidgey AP, Boyd RL (1998) Positive selection of low responsive potentially autoreactive T cells induced by high avidity, non-deleting interactions. Int Immunol 10:999–1008
Cohn M, Langman RE (1990) The unit of humoral immunity selected by evolution. Immunol Rev 115: 7–142
Cook JR, Wormstall E-M, Hornell T, Russell J, Connolly JM, Hansen TH (1997) Quantitation of the cell surface level of Ld resulting in positive versus negative selection of the 2 C transgenic T cell receptor in vivo. Immunity 7:233–241
Crabtree GR, Clipstone NA (1994) Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu Rev Biochem 63:1045–1083
Davis SJ, van der Merwe PA (1996) The structure and ligand interactions of CD2: implications for T cell function. Immunol Today 17: 177–187
Delaney JR, Sykulev Y, Eisen HN, Tonegawa S (1998) Differences in the level of expression of class I major histocompatibility complex proteins on thymic epithelial and dendritic cells influence the decision of immature thymocytes between positive and negative selection. Proc Natl Acad Sci USA 95:5235–5240
Dustin ML, Olszowy MW, Holdorf AD, Li J, Bromley S, Desai N, Widder P, Rosenberger F, van der Merwe PA, Allen PM, Shaw AS (1998) A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell 94:667–677
Ehl S, Hoffmann-Rohrer U, Nagata S, Hengartner H, Zinkernagel R (1996) Diflerent susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo. J Immunol 156:2357–2360
Ehl S, Hombach J, Aichele P, Hengartner H, Zinkernagel RM (1997) Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J Exp Med 185:1241–1251
Fink PJ, Bevan MJ (1978) H-2 antigens of the thymus determine lymphocyte specificity. J Exp Med 148:766–775
Fukui Y, Ishimoto T, Utsuyama M, Gyotoku T, Koga T, Nakao K, Hirokawa K, Katsuki M, Sasazuki T (1997) Positive and negative CD4+ thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus. Immunity 6:401–410
Fung-Leung WP, Louie MC, Limmer A, Ohashi PS, Ngo K, Chen L, Kawai K, Lacy E, Loh DY, Mak TW (1993) The lack of CD8 alpha cytoplasmic domain resulted in a dramatic decrease in efficiency in thymic maturation but only a moderate reduction in cytotoxic function of CD8+ T lymphocytes. Eur J Immunol 23:2834–2840
Garza KM, Chan SM, Suri R, Nguyen LT, Odermatt B, Schoenberger SP, Ohashi PS (2000a) Role of antigen-presenting cells in mediating tolerance and autoimmunity. J Exp Med 191:2021–2027
Garza KM, McKall-Faienza KJ, Zakarian A, Odermatt B, Ohashi PS (2000b) Enhanced T cell responses contribute to the genetic predisposition of CD8-mediated spontaneous autoimmunity. Eur J Immunol, in press
Geiger T, Gooding LR, Flavell RA (1992) T-cell responsiveness to an oncogenic peripheral protein and spontaneous autoimmunity in transgenic mice. Proc Natl Acad Sci USA 89:2985–2989
Girao C, Hu Q, Sun J, Ashton-Rickardt PG (1997) Limits to the Differential Avidity Model of T Cell Selection in the Thymus. J Immunol 159:4205–4211
Goldrath AW, Hogquist KA, Bevan MJ (1997) CD8 lineage commitment in the absence of CD8. Immunity 6:633–642
Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM (1993) Transgenic mice that express a myelin basic protein specific T cell receptor develop spontaneous autoimmunity. Cell 72:551–560
Green DR, Scott DW (1994) Activation-induced apoptosis in lymphocytes. Curr Opin Immunol 6: 476–487
Grewal IS, Flavell RA (1998) CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16: 111–135
Grewal IS, Foellmer HG, Grewal KD, Xu J, Hardardottir F, Baron JL, Janeway Jr CA, Flavell RA (1996) Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273:1864–1867
Hanahan D (1985) Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315:115–122
Harlan DM, Hengartner H, Huang ML, Kang YH, Abe R, Moreadith RW, Pircher H, Gray GS, Ohashi PS, Freeman GJ, Nadler LM, June CH, Aichele P (1994) Mice expressing both B7 and viral glycoprotien on pancreatic beta cells along with glycoprotein-specific transgenic T cell develop diabetes due to a breakdown of T lymphocyte unresponsiveness. Proc Natl Acad Sci USA 91:3137–3141
Heath WR, Karamalis F, Donoghue J, Miller JFAP (1995) Autoimmunity caused by ignorant CD8+; T cell is transient and depends on avidity. J Immunol 155:2339–2349
Hernández-Hoyos G, Sohn SJ, Rothenberg EV, Alberola-Ila J (2000) Lck activity controls CD4/CD8 T cell lineage commitment. Immunity 12:313–322
Hogquist KA, Jameson SC, Bevan MJ (1995) Strong agonist ligands for the T cell receptor do not mediate positive selection of functional CD8+ T cells. Immunity 3:78–86
Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17–27
Hogquist KA, Tomlinson AJ, Kieper WC, McGargill MA, Hart MC, Naylor S, Jameson SC (1997) Identification of a naturally occurring ligand for thymic positive selection. Immunity 6:389–399
Hu Q, Bazemore-Walker CR, Girao C, Opferman JT, Sun J, Shabanowitz J, Hunt DF, Ashton-Rickardt PG (1997) Specific recognition of thymic selt-peptides induces the positive selection of cytotoxic T fymphocytes. Immunity 7:221–231
Ingold AL, Landel C, Knall C, Evans GA, Polter TA (1991) Co-engagement of CD8 with the T cell receptor is required for negative selection. Nature 352:721–723
Jameson SC, Hogquist KA, Bevan MJ (1994) Specificity and flexibility in thymic selection. Nature 369:750–752
Josien R, Wong BR, Li H-L, Steinman RM, Choi Y (1999) TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 162:2562–2568
Katz JD, Wang B, Haskins K, Benoist C, Mathis D (1993) Following a diabetogenic T cell from genesis through pathogenesis. Cell 74:1089–1100
Kawai K, Ohashi PS (1995) Immunological function of a defined T-cell population tolerized to low-affinity self antigens. Nature 374:68–69
Kägi D, Odermatt B, Ohashi PS, Zinkernagel RM, Hengartner H (1996) Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J Exp Med 183:2143–2152
Killeen N, Moriarty A, Teh HS, Littman DR (1992) Requirement for CD8-Major Histocompatibility Complex class I interaction in positive and negative selection of developing T cells. J Exp Med 176:89–97
Kisielow P, Blüthmann H, Staerz UD, Steinmetz M, von Boehmer H (1988) Tolerance in T cell receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333:742–746
Koller BH, Marrack P, Kappler JW, Smithies O (1990) Normal development of mice deficient in beta 2 M, MHC class I proteins, and CD8+ T cells. Science 248:1227–1230
Kurts C, Kosaka H, Carbone FR, Miller JFAP, Heath WR (1997) Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8+ T cells. J Exp Med 186:239–245
Kurts C, Sutherland RM, Davey G, Li M, Lew AM, Blanas E, Carbone FR, Miller JFAP, Heath WR (1999) CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci USA 96: 12703–12707
Kündig TM, Shahinian A, Kawai K, Mittruecker HW, Sebzda E, Bachmann MF, Mak TW, Ohashi PS (1996) Duration of TCR stimulation determines costimulatory requirements of T cells. Immunity 5:41–52
Kyburz D, Aichele P, Speiser DE, Hengartner H, Zinkernagel RM, Pircher H (1993) T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur J Immunol 23:1956–1962
Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S (1994) High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78:399–408
Lafferty KJ, Prowse SJ, Simeonovic CJ (1983) Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol 1: 143–173
Lenschow DJ, Walunas TL, Bluestone JA (1996) CD28/B7 system of T cell costimulation. Annu Rev Immunol 14:233–258
Lucas B, Stefanova I, Yasutomo K, Dautigny N, Germain RN (1999) Divergent changes in the sensitivity of maturing T cells to structurally related ligands underlies formation of a useful T cell repertoire. Immunity 10:367–376
Ludewig B, Ochsenbein AF, Odermatt B, Paulin D, Hengartner H, Zinkernagel RM (2000) Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J Exp Med 191:795–803
Ludewig B, Odermatt B, Landmann S, Hengartner H, Zinkernagel RM (1998) Dendritic cells induce autoimmune diabetes and maintain disease via De Novo formation of local lymphoid tissue. J Exp Med 188:1493–1501
Mamula MJ (1993) The inability to process a self-peptide allows auto reactive T cells to escape tolerance. J Exp Med 177:567–571
Mariathasan S, Bachmann MF, Bouchard D, Ohteki T, Ohashi PS (1998) Degree of TCR internalization and Ca2+ flux correlates with thymocyte selection. J Immunol 161:6030–6037
Marrack P, Kappler J (1988) The T-cell repertoire for antigen and MHC. Immunol Today 9:308–315
Martin S, Bevan MJ (1998) Transient alteration of T cell fine specificity by a strong primary stimulus correlates with T cell receptor down-regulation. Eur J Immunol 28:2991–3002
Matechak EO, Killeen N, Hedrick SM, Fowlkes BJ (1996) MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent. Immunity 4:337–347
McKall-Faienza K, Kawai K, Kündig TM, Odermatt B, Bachmann MF, Zakarian A, Mak TW, Ohashi PS (1998) Absence of TNFRp55 influences virus-induced autoimmunity despite efficient lymphocytic infiltration. Int Immunol 10:405–412
Meuer SC, Hussey RE, Cantrell DA, Hodgdon JC, Schlossman SF, Smith KA, Reinherz EL (1984) Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. Proc Natl Acad Sci USA 81:1509–1513
Morgan DJ, Kreuwel HTC, Sherman LA (1999) Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. J Immunol 163:723–727
Moskophidis D, Lechner F, Pircher H, Zinkernagel RM (1993) Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758–761
Murphy KM, Weaver CT, Elish M, Allen PM, Loh DY (1989) Peripheral tolerance to allogeneic class II histocompatibility antigens expressed in transgenic mice: evidence against a clonal-deletion mechanism. Proc Natl Acad Sci USA 86:10034–10038
Nguyen LT, McKall-Faienza K, Zakarian A, Speiser DE, Mak TW, Ohashi PS (2000) TNF receptor 1 (TNFR1) and CD95 are not required for T cell deletion after virus infection but contribute to peptide-induced deletion under limited conditions. Eur J Immunol 30:683–688
Oehen S, Ohashi PS, Aichele P, Hengartner H, Zinkernagel RM (1992) Vaccination or tolerance to prevent diabetes. Eur J Immunol 22:3149–3153
Ohashi PS, Oehen S, Aichele P, Pircher H, Odermatt B, Herrera P, Higuchi Y, Buerki K, Hengartner H, Zinkernagel RM (1993a) Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and TNF-α. J Immunol 150:5185–5194
Ohashi PS, Oehen S, Bürki K, Pircher H, Ohashi CT, Odermatt B, Malissen B, Zinkernagel R, Hengartner H (1991) Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305–317
Ohashi PS, Pircher H, Burki K, Zinkernagel RM, Hengartner H (1990) Distinct sequence of negative or positive selection implied by thymocyte T cell receptor densities. Nature 346:861–863
Ohashi PS, Zinkernagel RM, Luescher IF, Hengartner H, Pircher H (1993b) Enhanced positive selection of a transgenic TCR by a restriction element that does not permit negative selection. Int Immunol 5:131–138
Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H (1991) Virus infection triggers insulindependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65:319–331
Pircher H, Burki K, Lang R, Hengartner H, Zinkernagel R (1989) Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342:559–561
Pircher H, Hoffmann Rohrer U, Moskophidis D, Zinkernagel RM, Hengartner H (1991) Lower receptor avidity required for thymic clonal deletion than for effector T cell function. Nature 351:482–485
Pircher H, Mak TW, Lang R, Ballhausen W, Rüedi E, Hengartner H, Zinkernagel RM, Bürki K (1989) T cell tolerance to Mlsa encoded antigens in T cell receptor β-chain transgenic mice. EMBO J 8:719–727
Pircher H, Michalopoulos EE, Iwamoto A, Ohashi PS, Baenziger J, Hengartner H, Zinkernagel RM, Mak TW (1987) Molecular analysis of the antigen receptor of virus-specific cytotoxic T cells and identification of a new V-alpha family. Eur J Immunol 17: 1843–1846
Qian D, Weiss A (1997) T cell antigen receptor signal transduction. Curr Opin Cell Biol 9:205–212
Rammensee H-G, Kroschewski R, Frangoulis B (1989) Clonal anergy induced in mature V β 6+ T lymphocytes on immunizing Mls-1b mice with Mls-la expressing cells. Nature 339:541–544
Ramsdell F, Lantz T, Fowlkes BJ (1989) A nondeletional mechanism of thymic self tolerance. Science 246: 1038–1041
Reich A, Korner H, Sedgwick JD, Pircher H (2000) Immune down-regulation and peripheral deletion of CD8 T cells does not require TNF receptor-ligand interactions nor CD95. Eur J Immunol 30:678–682
Reich Z, Boniface JJ, Lyons DS, Borochov N, Wachtel EJ, Davis MM (1997) Ligand-specific oligo-merization of T-cell receptor molecules. Nature 387:617–620
Rocha B, von Boehmer H (1991) Peripheral selection of the cell repertoire. Science 251:1225–1228
Roman LM, Simons LF, Hammer RE, Sambrook JF, Gething M-JH (1990) The expression of influenza virus hemagglutinin in the pancreatic β cells of transgenic mice results in autoimmune diabetes. Cell 61:383–396
Rötzschke O, Falk K, Strominger JL (1997) Superactivation of an immune response triggered by oligomerized T cell epitopes. Proc Natl Acad Sci USA 94: 14642–14647
Ruedl C, Kopf M, Bachmann MF (1999) CD8(+) T cells mediate CD40-independent maturation of dendritic cells in vivo. J Exp Med 189: 1875–1884
Russell JH, Rush B, Weaver C, Wang R (1993) Mature T cells of autoimmune 1pr/1pr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 90:4409–4413
Salzmann M, Bachmann MF (1998) The role of T cell receptor dimerization in T cell antagonism and T cell specificity. Mol Immunol 53:271–277
Sarukhan A, Lanoue A, Franzke A, Brousse N, Buer J, von Boehmer H (1998) Changes in function of antigen-specific lymphocytes correlating with progression towards diabetes in a transgenic model. EMBO J 17:71–80
Schild HJ, Rötzschke O, Kalbacher H, Rammensee H-G (1990) Limit of T cell tolerance to self proteins by peptide presentation. Science 247:1587–1589
Schwartz RH (1990) A cell culture model for T lymphocyte clonal anergy. Science 248: 1349–1356
Scott B, Liblau R, Degermann S, Marconi LA, Ogata L, Caton AJ, McDevitt HO, Lo D (1994) A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1:73 82
Scott DE, Kisch WJ, Steinberg AD (1993) Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice. J Immunol 150:664–672
Screaton G, Xu X-N (2000) T cell life and death signalling via TNF-receptor family members. Curr Opin Immunol 12:316–322
Sebzda E, Choi M, Fung-Leung WP, Mak TW, Ohashi PS (1997) Peptide-induced positive selection of TCR transgenic thymocytes in a coreceptor-independent manner. Immunity 6:643–653
Sebzda E, Köndig TM, Thomson CT, Aoki K, Mak SY, Mayer J, Zamborelli TM, Nathenson S, Ohashi PS (1996) Mature T cell reactivity altered by a peptide agonist that induces positive selection. J Exp Med 183: 1093–1104
Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, Ohashi PS (1999) Selection of the T cell repertoire. Annu Rev Immunol 17:829–874
Sebzda E, Wallace VA, Mayer J, Yeung RSM, Mak TW, Ohashi PS (1994) Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science 263:1615–1618
Sha WC, Nelson CA, Newberry RD, Kranz DM, Russell JH, Loh DY (1988) Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336:73–76
Sha WC, Nelson CA, Newberry RD, Pullen JK, Pease LR, Russell JH, Loh DY (1990) Positive selection of transgenic receptor-bearing thymocytes by Kb antigen is altered by Kb mutations that involve peptide binding. Proc Natl Acad Sci USA 87:6186–6190
Singer GG, Abbas AK (1994) The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365–371
Soldevila G, Geiger T, Flavell RA (1995) Breaking immunologic ignorance to an antigenic peptide of simian virus 40 large T antigen. J Immunol 155:5590–5600
Speiser DE, Miranda R, Zakarian A, Bachmann MF, McKall-Faienza K, Odermatt B, Hanahan D, Zinkernagel RM, Ohashi PS (1997) Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J Exp Med 186:645–653
Speiser DE, Sebzda E, Ohteki T, Bachmann MF, Pfeffer K, Mak TW, Ohashi PS (1996) Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur J Immunol 26:3055–3060
Sprent J, Lo D, Gao E, Ron Y (1988) T cell selection in the thymus. Immunol Rev 101:173–190
Suzuki H, Punt JA, Granger LG, Singer A (1995) Asymmetric signalling requirements for thymocyte commitment to the CD4+ versus CDS+ T cell lineages: a new perspective on thymic commitment and selection. Immunity 2:413–425
Teh SJ, Dutz JP, Motyka B, Teh HS (1996) Fas (CD95)-independent regulation of immune responses by antigen-specific CD4+CD+ T cells. Int Immunol 8:675–681
Valitutti S, Müller S, Cella M, Padovan E, Lanzavecchia A (1995) Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375: 148–151
Valitutti S, Müller S, Salio M, Lanzavecchia A (1997) Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation. J Exp Med 185:1859–1864
Van Kaer L, Ashton-Rickardt PG, Ploegh HL, Tonegawa S (1992) TAP1 mutant mice are deficient in antigen presentation, surface class I molecules. and CD4-CD8+ T cells. Cell 71:1205–1214
Van Pel A, van der Bruggen P, Coulie PG, Brichard VG, Lethe B, Van den Eynde B, Uyttenhove C, Renauld J-C, Boon T (1995) Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol Rev 145:229–250
Viola A, Lanzavecchia A (1996) T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104–106
von Boehmer H (1996) CD4/CD8 lineage commitment: back to instruction? J Exp Med 183:713–715
von Herrath MG, Dockter J, Oldstone MBA (1994) How virus induces a rapid or slow onset insulindependent diabetes mellitus in a transgenic model. Immunity 1:231–242
von Herrath MG, Guerder S, Lewicki H, Flavell RA, Oldstone MBA (1995) Coexpression of B7-1 and viral (“self”) transgenes in pancreatic β cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 3:727–738
Watts TH, DeBenedette MA (1999) T cell co-stimulatory molecules other than CD28. Curr Opin Immunol 11:286–293
Webb S, Morris C, Sprent J (1990) Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63:1249–1256
Wong BR, Josien R, Lee SY, Sauter B, Li H-L, Steinman RM, Choi Y (1997a) TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186:2075–2080
Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao WN, Kalachikov S, Cayani E, Bartlett FS, Frankel WN, Lee SY, Choi Y (1997b) TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272:25190–25194
Yang Y, Wilson JM, (1996) CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 273:1862–1864
Zimmermann C, Brduscha-Riem K, Blaser C, Zinkernagel RM, Pircher H (1996a) Visualisation, characterization and turnover of CD8 + memory T cells in virus-infected hosts. J Exp Med 183: 1367–1375
Zimmermann C, Prevost-Blondel A, Blaser C, Pircher H (1999) Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences. Eur J Immunol 29:284–290
Zimmermann C, Rawiel M, Blaser C, Kaufmann M, Pircher H (1996b) Homeostatic regulation of CD8+ T cells after antigen challenge in the absence of Fas (CD95). Eur J Immunol 26:2903–2910
Zinkernagel RM, Callahan GN, Althage A, Cooper S, Klein PA, Klein J (1978a) On the thymus in the differentiation of “H-2 self-recognition” by T cells: evidence for dual recognition? J Exp Med 147:882–896
Zinkernagel RM, Callahan GN, Klein J, Dennert G (1978b) Cytotoxic T cells learn specificity for self H-2 during differentiation in the thymus. Nature 271:251–253
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Nguyen, L.T., Bachmann, M.F., Ohashi, P.S. (2002). Contribution of LCMV Transgenic Models to Understanding T Lymphocyte Development, Activation, Tolerance, and Autoimmunity. In: Oldstone, M.B.A. (eds) Arenaviruses II. Current Topics in Microbiology and Immunology, vol 263. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56055-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-56055-2_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62724-8
Online ISBN: 978-3-642-56055-2
eBook Packages: Springer Book Archive